CrownBio และ NEXT Oncology ประกาศความร่วมมือเชิงกลยุทธ์ในโมเดล PDX
October 30, 2019 01:47 ET
|
Crown Bioscience
ซานดิเอโก, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience ได้ประกาศความร่วมมือเชิงกลยุทธ์กับ NEXT Oncology ในวันนี้ เพื่อส่งมอบโมเดล PDX ที่เกี่ยวข้องทางคลินิกใหม่สำหรับการพัฒนายาพรีคลินิก...
크라운바이오, NEXT Oncology와 PDX 모델 공급을 위한 전략적 파트너십 체결
October 30, 2019 01:47 ET
|
Crown Bioscience
미국 샌디에이고, Oct. 30, 2019 (GLOBE NEWSWIRE) -- 크라운 바이오사이언스(Crown Bioscience)는 NEXT Oncology와 임상적 의미를 갖는 전임상 신약 개발용 새로운 PDX(환자 유래 동물 실험) 모델 공급을 위한 전략적 협업을 진행할 것이라고 발표했다. 이번 협약을 통해 크라운바이오는 향후 5년 간 NEXT...
CrownBio und NEXT Oncology geben strategische PDX-Modellpartnerschaft bekannt
October 29, 2019 08:42 ET
|
Crown Bioscience
SAN DIEGO, Kalifornien, USA, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience gab heute eine strategische Zusammenarbeit mit NEXT Oncology bekannt, um neue klinisch relevante PDX-Modelle für die...
CrownBio et NEXT Oncology annoncent un partenariat stratégique portant sur les modèles PDX
October 29, 2019 08:42 ET
|
Crown Bioscience
SAN DIEGO, 29 oct. 2019 (GLOBE NEWSWIRE) -- Crown Bioscience a annoncé aujourd'hui une collaboration stratégique avec NEXT Oncology dont le but est de fournir de nouveaux modèles PDX cliniquement...
CrownBio and NEXT Oncology Announce Strategic PDX Model Partnership
October 28, 2019 08:30 ET
|
Crown Bioscience
~ Agreement adds 350 premium tumor PDX models to world’s largest PDX collection ~ SAN DIEGO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience today announced a strategic collaboration...
Patient-Derived Tumor Organoid Drug Development Platform Launched
October 17, 2019 08:39 ET
|
Crown Bioscience
SAN DIEGO, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience today announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the...
Crown Bioscience Announces Four New Preclinical NASH Models In Development
June 12, 2019 08:00 ET
|
Crown Bioscience
SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
CrownBio and Hubrecht Organoid Technology Announce a Strategic Partnership, including Exclusive License to Provide Oncology Organoid-Based Preclinical Drug Development and Validation Services
March 27, 2019 08:00 ET
|
Crown Bioscience
SAN DIEGO, March 27, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company, providing translational platforms to advance oncology, inflammation and...
Crown Bioscience to Present Latest Advancements in Preclinical and Translational Platforms at AACR Annual Meeting 2019
March 21, 2019 08:30 ET
|
Crown Bioscience
SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model
March 12, 2019 08:30 ET
|
Crown Bioscience
SAN DIEGO, Calif. and WILMINGTON, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance...